Literature DB >> 11860983

Foveal hypoplasia in oculocutaneous albinism demonstrated by optical coherence tomography.

Carsten H Meyer1, Deborah J Lapolice, Sharon F Freedman.   

Abstract

PURPOSE: To document, in vivo, the foveal morphology and thickness in a patient with oculocutaneous albinism.
METHODS: Observational case report. In a 10-year-old female with oculocutaneous albinism, multiple cross-sectional scans of the fovea were performed using optical coherence tomography.
RESULTS: Optical coherence tomography scans were unable to detect the foveal pit. A widespread thickening of the retina occurred throughout the entire fovea with no difference from the surrounding macula. The foveal thickness was greater than 300 microm in the eyes of this patient with oculocutaneous albinism, compared with 150 microm in the normal eye. The inner retina had a highly reflective signal on optical coherence tomography.
CONCLUSION: Optical coherence tomography demonstrated in the anatomical location of the fovea a highly reflective inner retinal signal, possibly consistent with multiple layers of ganglion cells, and it confirmed foveal hypoplasia in a patient with oculocutaneous albinism.

Entities:  

Mesh:

Year:  2002        PMID: 11860983     DOI: 10.1016/s0002-9394(01)01326-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  19 in total

1.  Chiasmal misrouting and foveal hypoplasia without albinism.

Authors:  M M van Genderen; F C C Riemslag; J Schuil; F P Hoeben; J S Stilma; F M Meire
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

2.  Correlation between electroretinography, foveal anatomy and visual acuity in albinism.

Authors:  Zhaohui Hu; Kai Wang; Morgan Bertsch; Taylor Dunn; Taylor Kehoe; Andrew D Kemerley; Megan Helms; Sajag Bhattarai; Wanda Pfeifer; Todd E Scheetz; Arlene V Drack
Journal:  Doc Ophthalmol       Date:  2019-03-29       Impact factor: 2.379

3.  Idiopathic, isolated fovea plana with bilateral off-centre multifocal ERGs.

Authors:  Alice D McTrusty; Daphne L McCulloch; Niall C Strang; Angela McCall; Stuart Parks; Alison Brown; Graeme J Kennedy
Journal:  Doc Ophthalmol       Date:  2013-02-19       Impact factor: 2.379

4.  Macular structural characteristics in children with Down syndrome.

Authors:  Scott O'Brien; Jingyun Wang; Heather A Smith; Dana L Donaldson; Kathryn M Haider; Gavin J Roberts; Derek T Sprunger; Daniel E Neely; David A Plager
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-02       Impact factor: 3.117

Review 5.  The use of optical coherence tomography in intraoperative ophthalmic imaging.

Authors:  Paul Hahn; Justin Migacz; Rachelle O'Connell; Ramiro S Maldonado; Joseph A Izatt; Cynthia A Toth
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2011-07

6.  Macular optical coherence tomography findings and GPR143 mutations in patients with ocular albinism.

Authors:  H E Sepúlveda-Vázquez; C Villanueva-Mendoza; J C Zenteno; V Villegas-Ruiz; E Pelcastre-Luna; G García-Aguirre
Journal:  Int Ophthalmol       Date:  2014-02-14       Impact factor: 2.031

7.  Spectral domain optical coherence tomography for detection of foveal morphology in patients with nystagmus.

Authors:  Tara H Cronin; Richard W Hertle; Hiroshi Ishikawa; Joel S Schuman
Journal:  J AAPOS       Date:  2009-12       Impact factor: 1.220

8.  Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children.

Authors:  Ramiro S Maldonado; Joseph A Izatt; Neeru Sarin; David K Wallace; Sharon Freedman; C Michael Cotten; Cynthia A Toth
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

9.  Visual insignificance of the foveal pit: reassessment of foveal hypoplasia as fovea plana.

Authors:  Michael F Marmor; Stacey S Choi; Robert J Zawadzki; John S Werner
Journal:  Arch Ophthalmol       Date:  2008-07

10.  Isolated foveal hypoplasia.

Authors:  Giuseppe Querques; Francesco Prascina; Cristiana Iaculli; Nicola Delle Noci
Journal:  Int Ophthalmol       Date:  2008-04-10       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.